Showing results (81-90 of 165) with videos related to

Sort By:
Pageof 17
The American Journal of Physiology|November 1, 1993
Interaction of hypokalemia and ventricular dilatation in isolated rabbit heartsM J Reiter, D E Mann, G R Williams
Pacing and Clinical Electrophysiology : PACE|October 30, 1998
Inappropriate shock therapy for nonsustained ventricular tachycardia in a dual chamber pacemaker defibrillatorD E Mann, P A Kelly, M J Reiter
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1981
Comparison of croton oil and cantharidin induced inflammations of the mouse ear and their modification by topically applied drugsK F Swingle, M J Reiter, D H Schwartzmiller
The American Journal of Cardiology|January 1, 1983
Clinical spectrum of ventricular tachycardia with left bundle branch morphologyM J Reiter, W M Smith, J J Gallagher
Journal of Electrocardiology|January 1, 1992
Effect of pacing drive cycle length on induction of sustained monomorphic ventricular tachycardiaD E Mann, R C Florek, M J Reiter
The American Journal of Cardiology|June 1, 1987
Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery diseaseM J Reiter, A R Easley, D E Mann
The American Journal of Cardiology|September 15, 1994
Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study GroupJ L Anderson, M L Platt, T Guarnieri, et al.
Circulation|March 1, 1977
Ventricular apical vents and postoperative focal contraction abnormalities in patients undergoing coronary artery bypass surgeryR A Shaw, Y Kong, E L Pritchett, et al.
Journal of Electrocardiology|April 1, 1991
Atrioventricular nodal reentrant tachycardia initiated by catecholamine-induced ventricular tachycardia. A case reportD E Mann, P Marmont, J Shultz, et al.
The American Journal of Cardiology|April 15, 1997
Sotalol for ventricular tachyarrhythmias: beta-blocking and class III contributions, and relative efficacy versus class I drugs after prior drug failure. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic MonitoringJ A Reiffel, E Hahn, V Hartz, et al.
Pageof 17